See All Slides - tctmd.com

Slides

Presentation TCT 2012

TAVR in a Patient with Severely Depressed Left Ventricular Ejection Fraction

Presenter: Ariel Roguin

October 25, 2012

Presentation TCT 2012

The Aortic Root is the Only Way to Go - No Need for a Debate!

Presenter: Vinayak Bapat

October 25, 2012

Presentation TCT 2012

Should emergent catheterization be performed in all patients resuscitated from out of hospital cardiac arrest?

Presenter: Graham Nichol

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

A View from a Small Medical Device Company

Presenter: Stephen Rowland

October 25, 2012

Presentation TCT 2012

Case 1: Late Prosthesis Embolization

Presenter: David Smyth

October 25, 2012

$SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients$

Presentation TCT 2012

SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients

Presenter: Deepak Bhatt

October 25, 2012

Presentation TCT 2012

Functional Assessment of Coronary Artery Stenosis After Coronary Artery Bypass Graft

Presenter: Ioannis (John) Kanakakis

October 25, 2012

Presentation TCT 2012

Complications of Transradial Access

Presenter: Philippe Genereux

October 25, 2012

Presentation TCT 2012

Mitral Valve Bioprosthesis Degeneration with Perivalvular Leak: When One Door Closes, Another Opens

Presenter: Sergio Berti

October 25, 2012

Advertisement

Slides

TAVR in a Patient with Severely Depressed Left Ventricular Ejection Fraction

The Aortic Root is the Only Way to Go - No Need for a Debate!

Should emergent catheterization be performed in all patients resuscitated from out of hospital cardiac arrest?

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

A View from a Small Medical Device Company

Case 1: Late Prosthesis Embolization

SIMPLICITY 3 Update: Issues with Enrolling Refractory Patients

Functional Assessment of Coronary Artery Stenosis After Coronary Artery Bypass Graft

Complications of Transradial Access

Mitral Valve Bioprosthesis Degeneration with Perivalvular Leak: When One Door Closes, Another Opens

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content